What You Should Know:
– Eli Lilly and Company (Lilly) and Amazon Pharmacy today announced a strategic collaboration to improve patient access to GLP-1 medications for diabetes, obesity, and migraines.
– The partnership aims to improve access to these treatments and empower patients with the support they need to manage their chronic conditions.
Addressing a Growing Need
Millions of Americans struggle with diabetes, obesity, and related conditions. Nearly one in three adults (approximately 98 million) have prediabetes, while 40 million have diabetes. Additionally, over 40% of U.S. adults are considered obese. Treatments for these conditions hold promise, but access to newer medications can be limited.
LillyDirect and Amazon Pharmacy: A Convenient Solution
Through LillyDirect, a platform connecting patients with healthcare providers and pharmacies, patients can now receive select Lilly medications delivered directly to their homes via Amazon Pharmacy. This partnership offers several benefits:
- Fast and Free Delivery: Patients can receive their medications quickly and conveniently, with free two-day delivery for Prime members.
- 24/7 Clinical Pharmacist Support: Amazon Pharmacy’s team of clinical pharmacists provides patients with ongoing support, including medication review for accuracy, guidance on administration techniques, information on drug interactions and side effects, and cost considerations.
- Enhanced Medication Adherence: Pharmacists can also offer medication reminder tools to help patients stay on track with their treatment plans.
Multiple Options for Prescriptions
Physicians can send prescriptions to either LillyDirect Pharmacy Solutions or directly to Amazon Pharmacy. For a complete list of Lilly medications available through LillyDirect, visit https://lillydirect.lilly.com/medicines. For more information about Amazon Pharmacy and its medication offerings, visit their website at https://pharmacy.amazon.com/.
